title: Limitations of the diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO)
authors.forename: H
authors.initials: H
authors.lastname: Iwata
authors.forename: M
authors.initials: M
authors.lastname: Kami
authors.forename: Y
authors.initials: Y
authors.lastname: Kishi
authors.forename: Y
authors.initials: Y
authors.lastname: Oki
authors.forename: Y
authors.initials: Y
authors.lastname: Tanaka
authors.forename: K
authors.initials: K
authors.lastname: Takeuchi
authors.forename: I
authors.initials: I
authors.lastname: Yamazaki
authors.forename: R
authors.initials: R
authors.lastname: Suzuki
authors.forename: S
authors.initials: S
authors.lastname: Morinaga
authors.forename: Y
authors.initials: Y
authors.lastname: Mutou
mesh_terms: D000208:Acute Disease; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D003937:Diagnosis, Differential; D006801:Humans; D016130:Immunophenotyping; D007951:Leukemia, Myeloid / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D014411:Neoplastic Stem Cells / Q000737:chemistry / Q000648:ultrastructure; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000188:drug therapy; D012015:Reference Standards; D012074:Remission Induction
chemical_list: D014408:Biomarkers, Tumor